Health-related Quality of Life With Mosunetuzumab Plus Polatuzumab Vedotin in R/R LBCL: Phase 3 SUNMO Trial

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

Аннотация

Publication date: Available online 12 October 2026 Source: Clinical Lymphoma Myeloma and Leukemia Author(s): Won-Seog Kim, Huilai Zhang, Dai Maruyama, Astrid Pavlovsky, Eduardo M. Rego, Huangming Hong, Hideki Goto, Mark Fesler, Boone Goodgame, Zhiming Li, Adam J. Olszewski, Joan Ashby, Shen Yin, Wahib S. Ead, Martin Janousek, Song Pham, Connie L. Batlevi, Michael C. Wei, Jason Westin, Lihua E. Budde

Читать у издателя →

Похожие статьи